English
French
German
Italian
Russian
Spanish
KKR in talks to buy Spanish fertility clinic company Eugin from Fresenius -report
KKR in talks to buy Spanish fertility clinic company Eugin from Fresenius -report By Reuters
Breaking News
‘;
Published Oct 02, 2023 02:59AM ET
Updated Oct 02, 2023 03:10AM ET
(C) Reuters. General view of the Fresenius SE logo on the company’s headquarters in Bad Homburg near Frankfurt, Germany, February 25, 2015. REUTERS/Ralph Orlowski/File Photo/File Photo
MADRID (Reuters) – United States-based buyout fund KKR is in exclusive talks with Germany’ Fresenius to buy Eugin, fertility clinics in Spain and Portugal, Spanish newspaper Cinco Dias reported on Monday citing unidentified financial sources.
A potential deal would value Eugin at around 500 million euros ($528.55 million), the newspaper said.
KKR would buy the clinics with a Spanish partner, it added.
The U.S. fund already owns assets in the industry in the country, Cinco Dias reported.
KKR, Fresenius and Eugin did not immediately respond to messages seeking comment.
($1 = 0.9460 euros)
KKR in talks to buy Spanish fertility clinic company Eugin from Fresenius -report
Terms And Conditions
Privacy Policy
Risk Warning
Do not sell my personal information
(C) 2007-2023 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
